-
Continuous monitoring is critical if regulatory agencies such as the Food and Drug Administration are to reduce the risk in artificial and machine learning-based medical technology.December 9
-
Sen. Elizabeth Warren (D-Mass.) and two Senate colleagues are calling into question the statutory basis of a Food and Drug Administration software precertification program aimed at fast-tracking digital health products to market.October 31
-
The Food and Drug Administration is moving toward requiring more electronic submissions of safety reports for products being evaluated by the agency.October 30
-
The Food and Drug Administration has issued revised draft guidance on the categories of clinical decision support software subject to FDA oversight.October 1
-
The Food and Drug Administration has plans to make the database that houses medical device reports submitted to the agency more user friendly.June 24
-
The American Medical Informatics Association wants the Food and Drug Administration to improve its conceptual approach to regulating medical devices that leverage self-updating artificial intelligence algorithms.June 11
-
Agency is looking for volunteers planning to submit a De Novo Request or 510(k) submission to evaluate Pre-Cert working model.May 28
-
Agency reports that unauthorized system resulted in an insulin overdose requiring medical intervention.May 20
-
The Food and Drug Administration is proposing recommendations on how to better design studies to assess pregnancy outcomes in women exposed to FDA-regulated drugs and biological products.May 13
-
A Mount Sinai Health System startup, seeking to commercialize an artificial intelligence-enabled clinical diagnostic for kidney disease, has been granted priority regulatory review by the Food and Drug Administration.May 3
